The stock price dropped to $37.61, marking a new annual low and bringing the 12-month decline to 45%. This sharp sell-off followed a quarterly performance that missed Wall Street benchmarks on both revenue and profitability. According to FactSet data, Ryan Specialty reported fourth-quarter revenue of $751.2 million, falling short of the $777.1 million consensus estimate.

Disconnect in Growth Projections

Profitability also lagged behind forecasts, with adjusted earnings per share reaching 45 cents, compared to the 49 cents projected by analysts. The primary driver of investor concern, however, was the company's long-term outlook. While the firm expects 2026 revenue to increase by a high-single-digit percentage, analysts were modeling for 15% sales growth.

This discrepancy highlights a slowing growth trajectory for the insurance firm. Key performance metrics from the report include:

• A 15% drop in share price to a 52-week low.
• Quarterly revenue missing estimates by nearly $26 million.
• Long-term sales guidance trailing analyst projections by several percentage points.